Same Indication

Nivolumab vs Spironolactone

Nivolumab vs Spironolactone: Overview

This comparison examines the pharmacological differences between Nivolumab and Spironolactone.

Mechanism of Action

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Nivolumab β€” 27 days; Spironolactone β€” 1.4 hours.

Chemical Properties

Molecular Formula: Spironolactone β€” C24H32O4S.

Molecular Weight: Spironolactone β€” 416.5740 g/mol.

Type: Nivolumab β€” Antibody; Spironolactone β€” Small molecule.